6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice

BACKGROUND: Increased vascular permeability is a pathophysiological hallmark of sepsis and results in increased transcapillary leakage of plasma fluid, hypovolemia, and interstitial edema formation. 6% hydroxyethyl starch (HES 130/0.4) is commonly used to treat hypovolemia to maintain adequate organ...

Descripción completa

Detalles Bibliográficos
Autores principales: Margraf, Andreas, Herter, Jan M., Kühne, Katharina, Stadtmann, Anika, Ermert, Thomas, Wenk, Manuel, Meersch, Melanie, Van Aken, Hugo, Zarbock, Alexander, Rossaint, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930811/
https://www.ncbi.nlm.nih.gov/pubmed/29716625
http://dx.doi.org/10.1186/s13054-017-1846-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930811/
https://www.ncbi.nlm.nih.gov/pubmed/29716625
http://dx.doi.org/10.1186/s13054-017-1846-3

Ejemplares similares